Navinci welcomes Kjell Ruth as Chief Commercial Officer
Uppsala, Sweden – February 2, 2026 – Navinci today announced the appointment of Kjell Ruth as Chief Commercial Officer (CCO). In this role, Kjell will lead Navinci’s global commercial strategy and execution, supporting the company’s continued expansion worldwide.
Kjell brings broad, cross-functional experience from the biotech and life science industry, spanning business development, sales, marketing, and commercial strategy. He has worked across both high-growth biotech companies and larger global organizations, most recently in Global Marketing at Thermo Fisher Scientific. His experience from both the user and manufacturer sides of the life science ecosystem enables him to effectively align scientific innovation with real-world customer needs and adoption.
“I’m excited to join Navinci at a pivotal stage of its growth,” said Kjell Ruth, Chief Commercial Officer at Navinci. “The company has built a highly differentiated platform, and I look forward to working with the team to scale its commercial impact and expand global adoption.”
Jenny Sundqvist, CEO of Navinci, commented: “I’m thrilled to welcome Kjell to Navinci. With Kjell in place as Chief Commercial Officer, the new management team is complete, and we are set for our next chapter of growth and innovation. Kjell’s track record, experience and enthusiasm will be a valued asset in achieving our long-term ambitions. I’m also certain that Kjell’s positive attitude and easy-going friendly manners will fit right into Navinci’s culture.”
Kjell’s appointment underscores Navinci’s commitment to building a strong leadership team as the company continues to advance its commercial presence and support customers globally.
For further information, please contact:
Jenny Sundqvist, CEO
E-mail: jenny.sundqvist@navinci.se
About Navinci
Navinci is a Swedish biotech company specializing in developing innovative solutions for studying in situ protein expression and interactions. With a focus and a strong legacy in developing in situ proximity ligation assay technology, Navinci has established itself as a center of excellence in the field and has a broad portfolio of products that help researchers study protein interactions in depth.